Alterations in specific protein-tyrosine phosphatases accompany insulin resistance of streptozotocin diabetes, The American journal of physiology, vol.268, pp.932-940, 1995. ,
,
, SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production, Immunity, vol.25, pp.919-928
Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.4736-4741, 2009. ,
Mouse model of Noonan syndrome reveals cell typeand gene dosage-dependent effects of Ptpn11 mutation, Nature medicine, vol.10, pp.849-857, 2004. ,
Association of diabetes and hepatitis C infection: epidemiologic evidence and pathophysiologic insights, Current diabetes reports, vol.4, pp.194-198, 2004. ,
PTP1B and SHP2 in POMC neurons reciprocally regulate energy balance in mice, J. Clin. Invest, vol.120, pp.720-734, 2010. ,
Modulation of Gr1(low) monocyte subset impacts insulin sensitivity and weight gain upon high-fat diet in female mice, International journal of obesity, vol.41, pp.1805-1814, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01580410
, , 2011.
, Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis, Metabolism: clinical and experimental, vol.286, pp.9225-9235
Altered expression of insulin signaling components in streptozotocin-treated rats, Biochemical and biophysical research communications, vol.212, pp.933-938, 1995. ,
Growth patterns of patients with Noonan syndrome: correlation with age and genotype, European Federation of Endocrine Societies, vol.174, pp.641-650, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01662610
, , 2009.
, Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis, Blood, vol.113, pp.4414-4424
Identification of demethylincisterol A3 as a selective inhibitor of protein tyrosine phosphatase Shp2, European journal of pharmacology, vol.795, pp.124-133, 2017. ,
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases, Nature, vol.535, pp.148-152, 2016. ,
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors, Nature medicine, 2018. ,
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature, Proceedings of the National Academy of Sciences of the United States of America, vol.109, pp.4257-4262, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00756494
Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation, Am J Physiol Regul Integr Comp Physiol, vol.307, pp.1438-1447, 2014. ,
Apelin stimulates glucose utilization in normal and obese insulin-resistant mice, Cell metabolism, vol.8, pp.437-445, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00408948
Age-associated vascular inflammation promotes monocytosis during atherogenesis, Aging cell, vol.15, pp.766-777, 2016. ,
Allosteric Inhibition of SHP2: Identification of a Potent, Selective, and Orally Efficacious Phosphatase Inhibitor, Journal of medicinal chemistry, vol.59, pp.7773-7782, 2016. ,
Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis, Nature communications, vol.8, p.2168, 2017. ,
Development and Characterization of an Endotoxemia Model in Zebra Fish, Frontiers in immunology, vol.9, p.607, 2018. ,
The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome, European journal of human genetics : EJHG, vol.24, pp.690-696, 2016. ,
Acute stimulation of glucose metabolism in mice by leptin treatment, Nature, vol.389, pp.374-377, 1997. ,
Hepatic stellate cell-derived PDGFRalpha-enriched extracellular vesicles promote liver fibrosis in mice through SHP2, Hepatology, p.132, 2018. ,
Pleiotropic genes for metabolic syndrome and inflammation, Molecular genetics and metabolism, vol.112, pp.317-338, 2014. ,
Development of diabesity in mice with neuronal deletion of Shp2 tyrosine phosphatase, Am J Pathol, vol.172, pp.1312-1324, 2008. ,
Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome, Nature neuroscience, vol.17, pp.1736-1743, 2014. ,
Protein-tyrosine phosphatase Shp2 positively regulates macrophage oxidative burst, The Journal of biological chemistry, vol.290, pp.3894-3909, 2015. ,
Regulation of IRS-1/SHP2 interaction and AKT phosphorylation in animal models of insulin resistance, Endocrine, vol.18, pp.1-12, 2002. ,
Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance, The Journal of biological chemistry, vol.274, pp.30236-30243, 1999. ,
Altered glucose homeostasis in mice with liver-specific deletion of Src homology phosphatase 2, J. Biol. Chem, vol.285, pp.39750-39758, 2010. ,
Associations Between Type 2 Diabetes-Related Genetic Scores and Metabolic Traits, in Obese and Normal-Weight Youths, The Journal of clinical endocrinology and metabolism, vol.101, pp.4244-4250, 2016. ,
The COOH-terminal tyrosine phosphorylation sites on IRS-1 bind SHP-2 and negatively regulate insulin signaling, The Journal of biological chemistry, vol.273, pp.26908-26914, 1998. ,
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity, Cell metabolism, vol.19, pp.821-835, 2014. ,
Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis, Cell metabolism, vol.17, pp.695-708, 2013. ,
Hepatic SRC homology phosphatase 2 regulates energy balance in mice, Endocrinology, vol.153, pp.3158-3169, 2012. ,
Mediating ERK 1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome, J. Clin. Invest, vol.117, pp.2123-2132, 2007. ,
Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations, Proc. Natl. Acad. Sci. U. S. A, vol.106, pp.15436-15441, 2009. ,
Reciprocal regulation of TLR2-mediated IFN-beta production by SHP2 and Gsk3beta, Scientific reports, vol.7, p.6807, 2017. ,
Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance and Premature Death, Mol. Cell. Biol, vol.29, pp.378-388, 2009. ,
, , 1991.
, Body Mass Index variations: centiles from birth to 87 years, European journal of clinical nutrition, vol.45, pp.13-21
Selective inhibition of leukemia-associated SHP2(E69K) mutant by the allosteric SHP2 inhibitor SHP099, Leukemia, 2018. ,
LEOPARD syndromeassociated SHP2 mutation confers leanness and protection from diet-induced obesity, 2014. ,
, Proceedings of the National Academy of Sciences of the United States of America, vol.111, pp.4494-4503
SHP2 sails from physiology to pathology, European journal of medical genetics, vol.58, pp.509-525, 2015. ,
The Rasopathy family: Consequences of germline activation of the RAS/MAPK pathway, Endocrine reviews, 2018. ,
Hematopoietic ABCA1 deletion promotes monocytosis and worsens dietinduced insulin resistance in mice, Journal of lipid research, vol.57, pp.100-108, 2016. ,
Myeloid-specific disruption of tyrosine phosphatase Shp2 promotes alternative activation of macrophages and predisposes mice to pulmonary fibrosis, J Immunol, vol.193, pp.2801-2811, 2014. ,
Reference data for bone density and body composition measured with dual, 2002. ,
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus, The Journal of clinical investigation, vol.126, pp.2077-2092, 2016. ,
Inflammation, stress, and diabetes, The Journal of clinical investigation, vol.115, pp.1111-1119, 2005. ,
MEK-ERK pathway modulation ameliorates disease phenotypes in a mouse model of Noonan syndrome associated with the Raf1(L613V) mutation, J. Clin. Invest, vol.121, pp.1009-1025, 2011. ,
A germline gain-of-function mutation in Ptpn11 (Shp-2) phosphatase induces myeloproliferative disease by aberrant activation of hematopoietic stem cells, Blood, vol.116, pp.3611-3621, 2010. ,
, , 2017.
, Macrophage-Restricted Shp2 Tyrosine Phosphatase Acts as a Rheostat for MMP12 through TGF-beta Activation in the Prevention of Age-Related Emphysema in Mice, J Immunol, vol.199, pp.2323-2332
Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism, Proc. Natl. Acad. Sci. U. S. A, vol.101, pp.16064-16069, 2004. ,
, , 2002.
, Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2, Mol. Cell. Biol, vol.22, pp.4062-4072
Coordinated regulation by Shp2 tyrosine phosphatase of signaling events controlling insulin biosynthesis in pancreatic beta-cells, Proceedings of the National Academy of Sciences of the United States of America, vol.106, pp.7531-7536, 2009. ,
Shp2 Deficiency Impairs the Inflammatory Response Against Haemophilus influenzae by Regulating Macrophage Polarization, The Journal of infectious diseases, vol.214, pp.625-633, 2016. ,
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications, Nature reviews, vol.14, pp.88-98, 2018. ,
Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling, Molecular and Cellular Biology, vol.23, pp.7875-7886, 2003. ,
Molecular Mechanism for a Role of SHP2 in Epidermal Growth Factor Receptor Signaling, Molecular and Cellular Biology, vol.23, pp.7875-7886, 2003. ,
The c-Jun NH 2 -terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser 307, Journal of Biological Chemistry, vol.275, pp.9047-9054, 2000. ,
B-Cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the b-cell phenotype and maturity onset diabetes, Genes & Development, vol.12, pp.1763-1768, 1998. ,
Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation, Diabetic Medicine, vol.23, pp.469-480, 2006. ,
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B?, Current Biology, vol.7, pp.261-269, 1997. ,
Structural and Evolutionary Relationships among Protein Tyrosine Phosphatase Domains, Molecular and Cellular Biology, vol.21, pp.7117-7136, 2001. ,
Gain-of-Function Mutations in RIT1, 2013. ,
, Cause Noonan Syndrome, a RAS/MAPK Pathway Syndrome, The American Journal of Human Genetics, vol.93, pp.173-180
Noonan syndrome cardiac defects are caused by PTPN11 acting in endocardium to enhance endocardial-mesenchymal transformation, Proceedings of the National Academy of Sciences, vol.106, pp.4736-4741, 2009. ,
Mouse model of Noonan syndrome reveals cell type-and gene dosage-dependent effects of Ptpn11 mutation, Nature Medicine, vol.10, pp.849-857, 2004. ,
Tyrosyl Phosphorylation of Shp2 Is Required for Normal ERK Activation in Response to Some, but Not All, Growth Factors, Journal of Biological Chemistry, vol.278, pp.41677-41684, 2003. ,
IKK-? links inflammation to obesityinduced insulin resistance, Nature Medicine, vol.11, pp.191-198, 2005. ,
siRNA-Mediated Reduction of Inhibitor of Nuclear Factor-B Kinase Prevents Tumor Necrosis Factor--Induced Insulin Resistance in Human Skeletal Muscle, Diabetes, vol.57, pp.2066-2073, 2008. ,
An ERK/Cdk5 axis controls the diabetogenic actions of PPAR?, Nature, vol.517, pp.391-395, 2015. ,
and SHP2 in POMC neurons reciprocally regulate energy balance in mice, Journal of Clinical Investigation, vol.120, pp.720-734, 2010. ,
Ptpn11/Shp2 Acts as a Tumor Suppressor in Hepatocellular Carcinogenesis, Cancer Cell, vol.19, pp.629-639, 2011. ,
Concerted Functions of Gab1 and Shp2 in Liver Regeneration and Hepatoprotection, Molecular and Cellular Biology, vol.26, pp.4664-4674, 2006. ,
Revealing mechanisms for SH2 domain mediated regulation of the protein tyrosine phosphatase SHP-2, Structure, vol.6, pp.249-254, 1998. ,
Development of severe skeletal defects in induced SHP-2-deficient adult mice: a model of skeletal malformation in humans with SHP-2 mutations, Disease Models & Mechanisms, vol.4, pp.228-239, 2011. ,
Protein-tyrosine-phosphatase SHPTP2 couples platelet-derived growth factor receptor B to Ras, vol.91, pp.7335-7339, 1994. ,
Activating Mutations of the Noonan Syndrome-Associated Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia, Cancer Research, vol.64, pp.8816-8820, 2004. ,
Association of Protein Tyrosine Phosphatase 1B Gene Polymorphisms With Type 2 Diabetes, Diabetes, vol.53, pp.3007-3012, 2004. ,
Adipose-specific deletion of Src homology phosphatase 2 does not significantly alter systemic glucose homeostasis, Metabolism, vol.60, pp.1193-1201, 2011. ,
Protein Tyrosine Phosphatase 1B Deficiency Potentiates PERK/eIF2a Signaling in Brown Adipocytes, PLoS ONE, vol.7, p.10, 2012. ,
The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis, Diabetologia, vol.58, pp.2238-2246, 2015. ,
Health and Quality of Life in Adults with Noonan Syndrome, The Journal of Pediatrics, vol.161, pp.501-505, 2012. ,
FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis, American Journal of Physiology-Endocrinology and Metabolism, vol.283, pp.12-19, 2002. ,
Noonan and LEOPARD syndrome Shp2 variants induce heart displacement defects in zebrafish, 2014. ,
, Development, vol.141, 1961.
Short-term high-fat diet increases macrophage markers in skeletal muscle accompanied by impaired insulin signalling in healthy male subjects, Clinical Science, vol.128, pp.143-151, 2015. ,
Insulin Receptor Signaling in Normal and Insulin-Resistant States, Cold Spring Harbor Perspectives in Biology, vol.6, p.9191, 2014. ,
Reduced Activation of Phosphatidylinositol-3 Kinase and Increased Serine 636 Phosphorylation of Insulin Receptor Substrate-1 in Primary Culture of Skeletal Muscle Cells From Patients With Type 2 Diabetes, Diabetes, vol.52, pp.1319-1325, 2003. ,
SHP2 Regulates Chondrocyte Terminal Differentiation, Growth Plate Architecture and Skeletal Cell Fates AOM Wilkie, PLoS Genetics, vol.10, p.1004364, 2014. ,
Loss-of-Function Mutations in PTPN11 Cause Metachondromatosis, but Not Ollier Disease or Maffucci Syndrome AOM Wilkie, PLoS Genetics, vol.7, p.1002050, 2011. ,
Insulin Induces Specific Interaction between Insulin Receptor and Protein Kinase C in Primary Cultured Skeletal Muscle, Molecular Endocrinology, vol.15, pp.565-574, 2001. ,
The interplay between Src family kinases and receptor tyrosine kinases, Oncogene, vol.23, pp.7957-7968, 2004. ,
Inhibition of SHP2-mediated dephosphorylation of Ras suppresses oncogenesis, Nature Communications, p.6, 2015. ,
Shp2 signaling in POMC neurons is important for leptin's actions on blood pressure, energy balance, and glucose regulation, American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, vol.307, pp.1438-1447, 2014. ,
SH-PTP2Byp SH2 DomainBinding SpecificityIs Defined by Direct Interactions with Platelet-derived Growth Factor P-Receptor, Epidermal GrowthFactor Receptor, and Insulin Receptor Substrate-1-derived Phosphopeptides, The Journal of Biological Chemistry, vol.269, pp.10467-10474, 1994. ,
Postchallenge Glucose, A1C, and Fasting Glucose as Predictors of Type 2 Diabetes and Cardiovascular Disease: A 10-year prospective cohort study, Diabetes Care, vol.33, pp.2077-2083, 2010. ,
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells, Blood, vol.117, pp.4253-4261, 2011. ,
Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis, Blood, vol.113, pp.4414-4424, 2009. ,
Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor, Blood, vol.105, pp.3737-3742, 2005. ,
Shp-2 heterozygous hematopoietic stem cells have deficient repopulating ability due to diminished self-renewal, Experimental Hematology, vol.34, pp.1229-1238, 2006. ,
Preadipocyte Conversion to Macrophage: EVIDENCE OF PLASTICITY, Journal of Biological Chemistry, vol.278, pp.9850-9855, 2003. ,
Identification of Shp-2 as a Stat5A Phosphatase, Journal of Biological Chemistry, vol.278, pp.16520-16527, 2003. ,
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases, Nature, vol.535, pp.148-152, 2016. ,
Anti-inflammatory effect of lovastatin is mediated via the modulation of NF-?B and inhibition of HDAC1 and the PI3K/Akt/mTOR pathway in RAW264.7 macrophages, International Journal of Molecular Medecine, vol.41, pp.1103-1109, 2017. ,
LEOPARD Syndrome with a New Association of Congenital Corneal Tumor, Choristoma. Pediatric Dermatology, vol.20, pp.158-160, 2003. ,
Inhibition of IGF-I-related intracellular signaling pathways by proinflammatory cytokines in growth plate chondrocytes, Pediatric Research, vol.76, pp.245-251, 2014. ,
Prolactin Induces SHP-2 Association with Stat5, Nuclear Translocation, and Binding to the ?-Casein Gene Promoter in Mammary Cells, Journal of Biological Chemistry, vol.277, pp.31107-31114, 2002. ,
Opposing Actions of CSW and RasGAP Modulate the Strength of Torso RTK Signaling in the Drosophila Terminal Pathway, Molecular Cell, vol.2, pp.719-727, 1998. ,
The lipid phosphatase SHIP2 controls insulin sensitivity, Nature, vol.409, pp.92-97, 2001. ,
Insulin Reciprocally Regulates Glucagon Secretion in Humans, Diabetes, vol.59, pp.2936-2940, 2010. ,
Regulation of insulin sensitivity by serine/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2, Diabetologia, vol.55, pp.2565-2582, 2012. ,
The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway, Cellular Signalling, vol.20, pp.453-459, 2008. ,
SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors, Nature Medicine, vol.24, pp.512-517, 2018. ,
Structural mechanism associated with domain opening in gain-of-function mutations in SHP2 phosphatase, Proteins: Structure, Function, and Bioinformatics, vol.79, pp.1573-1588, 2011. ,
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation, Journal of Clinical Investigation, vol.99, pp.643-650, 1997. ,
Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation and Function by Mitogen-activated Protein Kinase, Journal of Biological Chemistry, vol.272, pp.31400-31406, 1997. ,
A Common Requirement for the Catalytic Activity and Both SH2 Domains of SHP-2 in Mitogen-activated Protein (MAP) Kinase Activation by the ErbB Family of Receptors, Journal of Biological Chemistry, vol.273, pp.16643-16646, 1998. ,
The Triumvirate: p-Cell, Muscle, Liver. A Collusion Responsible for NIDDM. Diabetes, p.37, 1988. ,
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus, Diabetes, vol.58, pp.773-795, 2009. ,
Type 2 diabetes mellitus, Nature Reviews Disease Primers, p.15019, 2015. ,
Tyrosine phosphatase SHP-2 mediates C-type lectin receptor-induced activation of the kinase Syk and anti-fungal TH17 responses, Nature Immunology, vol.16, pp.642-652, 2015. ,
Protein tyrosine phosphatases: mechanisms of catalysis and regulation, Current Biology, pp.633-641, 1998. ,
The double puzzle of diabetes, Nature, vol.423, pp.599-602, 2003. ,
Grouping of Multiple-Lentigines/LEOPARD and Noonan Syndromes on the PTPN11 Gene, The American Journal of Human Genetics, vol.71, pp.389-394, 2002. ,
High-Fat Diet: Bacteria Interactions Promote Intestinal Inflammation Which Precedes and Correlates with Obesity and Insulin Resistance in Mouse S Gaetani, PLoS ONE, vol.5, p.12191, 2010. ,
A comparative study of amino acid consumption by rat islet cells and the clonal betacell line BRIN-BD11 -the functional significance of L-alanine, Journal of Endocrinology, vol.179, pp.447-454, 2003. ,
Metabolic and Vascular Effects of Tumor Necrosis Factor-? Blockade with Etanercept in Obese Patients with Type 2 Diabetes, Journal of Vascular Research, vol.42, pp.517-525, 2005. ,
Islet Inflammation Impairs the Pancreatic ?-Cell in Type 2 Diabetes, Physiology, vol.24, pp.325-331, 2009. ,
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironment, Nature, vol.539, pp.304-308, 2016. ,
Inactivation of Hepatic Foxo1 by Insulin Signaling Is Required for Adaptive Nutrient Homeostasis and Endocrine Growth Regulation, Cell Metabolism, vol.8, pp.65-76, 2008. ,
Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity, Journal of Clinical Investigation, vol.103, pp.253-259, 1999. ,
, Mitochondrial Fusion Is Essential for Steroid Biosynthesis J-M Vanacker, vol.7, p.45829, 2012.
Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse, Cellular Signalling, vol.24, pp.1971-1980, 2012. ,
Functional Effects of PTPN11 (SHP2) Mutations Causing LEOPARD Syndrome on Epidermal Growth Factor-Induced Phosphoinositide 3-Kinase/AKT/Glycogen Synthase Kinase 3 Signaling, Molecular and Cellular Biology, vol.30, pp.2498-2507, 2010. ,
Saturated Fatty Acid and TLR Signaling Link ? Cell Dysfunction and Islet Inflammation, Cell Metabolism, vol.15, pp.518-533, 2012. ,
Amino Acid Stimulation of Glucagon Secretion by Perifused Islets of High-protein-fed Rats, Diabetes, vol.27, pp.370-376, 1978. ,
Increased Insulin Sensitivity and Obesity Resistance in Mice Lacking the Protein Tyrosine Phosphatase-1B Gene, Science, vol.283, pp.1544-1548, 1999. ,
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling, Journal of Biological Chemistry, vol.275, pp.15985-15991, 2000. ,
Noonan Syndrome-associated SHP-2/ Ptpn11 Mutants Enhance SIRP? and PZR Tyrosyl Phosphorylation and Promote Adhesion-mediated ERK Activation, Journal of Biological Chemistry, vol.283, pp.15328-15338, 2008. ,
Characterization of Human Adipose Tissue-Resident Hematopoietic Cell Populations Reveals a Novel Macrophage Subpopulation with CD34 Expression and Mesenchymal Multipotency, Stem Cells and Development, vol.22, pp.985-997, 2013. ,
Dominant and recessive inheritance of morbid obesity associated with melanocortin 4 receptor deficiency, Journal of Clinical Investigation, vol.106, pp.271-279, 2000. ,
Systemic inflammation disrupts the developmental program of white matter, Annals of Neurology, vol.70, pp.550-565, 2011. ,
SHP2 Inhibition Abrogates MEK inhibitor Resistance in Multiple Cancer Models, 2018. ,
Shp2 as a therapeutic target for leptin resistance and obesity, Expert Opinion on Therapeutic Targets, vol.10, pp.135-142, 2006. ,
Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans: Muscle Macrophages in Obesity and Diabetes, Obesity, vol.22, pp.747-757, 2014. ,
Metachondromatosis: more than just multiple osteochondromas, Journal of Children's Orthopaedics, vol.7, pp.455-464, 2013. ,
, Impact of Metformin-Induced Gastrointestinal Symptoms on Quality of Life and Adherence in Patients with Type, 2010.
, Diabetes. Postgraduate Medicine, vol.122, pp.112-120
Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation, Human Mutation, vol.23, pp.267-277, 2004. ,
Regulation of Insulin Synthesis and Secretion and Pancreatic Beta-Cell Dysfunction in Diabetes, Current Diabetes Reviews, vol.9, pp.25-53, 2013. ,
Thiazolidinediones improve ?cell function in type 2 diabetic patients, American Journal of Physiology-Endocrinology and Metabolism, vol.292, pp.871-883, 2007. ,
Partial Inhibition of Adipose Tissue Lipolysis Improves Glucose Metabolism and Insulin Sensitivity Without Alteration of Fat Mass S O'Rahilly, PLoS Biology, p.1001485, 2013. ,
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors, Nature, vol.518, pp.547-551, 2015. ,
Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line, Science, New Series, vol.301, pp.643-646, 2003. ,
Regulation of SREBP-1 expression and transcriptional action on HKII and FAS genes during fasting and refeeding in rat tissues, Journal of Lipid Research, vol.46, pp.697-705, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-02048999
Lovastatin decreases the synthesis of inflammatory mediators in the hippocampus and blocks the hyperthermia of rats submitted to long-lasting status epilepticus, Epilepsy & Behavior, vol.20, pp.1-5, 2011. ,
Inflammation and the developing brain: Consequences for hippocampal neurogenesis and behavior, Neuroscience & Biobehavioral Reviews, vol.40, pp.20-34, 2014. ,
Inflammatory Mechanisms in Obesity, Annual Review of Immunology, vol.29, pp.415-445, 2011. ,
) ?-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains, Endocrine Reviews, vol.28, pp.84-116, 2007. ,
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation, Biochimie, vol.87, pp.99-109, 2005. ,
Insulin receptor internalization and signalling, Insulin Action, pp.59-63, 1998. ,
The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis, p.9, 2009. ,
Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects, Proceedings of the National Academy of Sciences, vol.86, pp.2868-2872, 1989. ,
Insulin signaling, resistance, and metabolic syndrome: insights from mouse models into disease mechanisms, Journal of Endocrinology, vol.220, pp.1-23, 2014. ,
Tyrosine phosphatase SHP2 negatively regulates NLRP3 inflammasome activation via ANT1-dependent mitochondrial homeostasis, Nature Communications, vol.8, 2017. ,
The Caenorhabditis elegans SH2 domain-containing protein tyrosine phosphatase PTP-2 participates in signal transduction during oogenesis and vulval development, Genes & Development, vol.12, pp.571-585, 1998. ,
Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: Palliative treatment with a rapamycin analog, American Journal of Medical Genetics Part A, vol.167, pp.744-751, 2015. ,
Adipose tissue is an extramedullary reservoir for functional hematopoietic stem and progenitor cells, Blood, vol.115, pp.957-964, 2010. ,
Shp2, an SH2-containing Proteintyrosine Phosphatase, Positively Regulates Receptor Tyrosine Kinase Signaling by Dephosphorylating and Inactivating the Inhibitor Sprouty, Journal of Biological Chemistry, vol.279, pp.22992-22995, 2004. ,
Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway, Nature Cell Biology, vol.4, pp.850-858, 2002. ,
Reduced phosphatase activity of SHP-2 in LEOPARD syndrome: Consequences for PI3K binding on Gab1, FEBS Letters, vol.580, pp.2477-2482, 2006. ,
Shp2 Controls Female Body Weight and Energy Balance by Integrating Leptin and Estrogen Signals, Molecular and Cellular Biology, vol.32, pp.1867-1878, 2012. ,
Nonreceptor tyrosine phosphatase Shp2 promotes adipogenesis through inhibition of p38 MAP kinase, Proceedings of the National Academy of Sciences, vol.110, pp.79-88, 2013. ,
Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus, American Journal of Cardiovascular Drugs, vol.11, pp.115-128, 2011. ,
CREB regulates hepatic gluconeogenesis through the coactivator PGC-1, Nature, vol.413, pp.179-183, 2001. ,
Shp2/MAPK signaling controls goblet/paneth cell fate decisions in the intestine, Proceedings of the National Academy of Sciences, vol.111, pp.3472-3477, 2014. ,
Troglitazone prevents mitochondrial alterations, cell destruction, and diabetes in obese prediabetic rats, Proc. Natl. Acad. Sci, 1999. ,
Crystal Structure of the Tyrosine Phosphatase SHP-2, Cell, vol.92, pp.441-450, 1998. ,
Fatty acid-induced effect on glucagon secretion is mediated via fatty acid oxidation, Diabetes/Metabolism Research and Reviews, vol.23, pp.202-210, 2007. ,
Suppression of insulin feedback enhances the efficacy of PI3K inhibitors, Nature, vol.560, pp.499-503, 2018. ,
Adipose Expression of Tumor Necrosis Factor-x: Direct Role in Obesity-Linked Insulin Resistance, Science, vol.259, pp.87-91, 1993. ,
Development and Characterization of an Endotoxemia Model in Zebra Fish, Frontiers in Immunology, p.9, 2018. ,
Diet, Lifestyle, and the Risk of Type 2 Diabetes Mellitus in Women, The New England Journal of Medicine, vol.345, pp.790-797, 2001. ,
PTEN Expression Contributes to the Regulation of Muscle Protein Degradation in Diabetes, Diabetes, vol.56, pp.2449-2456, 2007. ,
Mutations of PTPN11 are rare in adult myeloid malignancies, Haematologica, vol.90, pp.853-854, 2005. ,
LEOPARD-type SHP2 mutant Gln510Glu attenuates cardiomyocyte differentiation and promotes cardiac hypertrophy via dysregulation of Akt/GSK-3 / -catenin signaling, American Journal of Physiology-Heart and Circulatory Physiology, vol.301, pp.1531-1539, 2011. ,
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome, Diabetes Care, vol.24, pp.683-689, 2001. ,
Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus, Nutrition & Metabolism, vol.7, p.83, 2010. ,
Human haematopoietic stem cell development: from the embryo to the dish, Development, vol.144, pp.2323-2337, 2017. ,
Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial, BMJ, vol.340, pp.2181-2181, 2010. ,
Nuclear Protein Tyrosine Phosphatase Shp-2 Is One Important Negative Regulator of Nuclear Export of Telomerase Reverse Transcriptase, Journal of Biological Chemistry, vol.283, pp.33155-33161, 2008. ,
Mapping a gene for Noonan syndrome to the long arm of chromosome 12, Nature Genetics, vol.8, pp.357-360, 1994. ,
SHP-2 and PI3-kinase genes PTPN11 and PIK3R1 may influence serum apoB and LDL cholesterol levels in normal women, 2007. ,
, Atherosclerosis, vol.194, pp.26-33
Reactive Oxygen Species Play a Critical Role in Collagen-Induced Platelet Activation SHP-2 Oxidation, Antioxidants & Redox Signaling, vol.20, pp.2528-2540, 2014. ,
Polymorphisms of PTPN11 gene could influence serum lipid levels in a sex-specific pattern, Lipids in Health and Disease, vol.12, p.72, 2013. ,
Glucagon and regulation of glucose metabolism, American Journal of Physiology-Endocrinology and Metabolism, vol.284, pp.671-678, 2003. ,
Shp2 Knockdown and Noonan/LEOPARD Mutant Shp2-Induced Gastrulation Defects, PLoS Genetics, vol.3, p.9, 2007. ,
Impact of Src Homology 2-Containing Inositol 5?-Phosphatase 2 Gene Polymorphisms Detected in a Japanese Population on Insulin Signaling, The Journal of Clinical Endocrinology & Metabolism, vol.90, pp.2911-2919, 2005. ,
Polymorphisms in Type II SH2 Domain-Containing Inositol 5-Phosphatase (INPPL1, SHIP2) Are Associated With Physiological Abnormalities of the Metabolic Syndrome, Diabetes, vol.53, pp.1900-1904, 2004. ,
SHP2-Mediated Signal Networks in Stem Cell Homeostasis and Dysfunction, Stem Cells International, pp.1-10, 2018. ,
SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development, Oncotarget, vol.8, 2017. ,
Weight Recidivism Post-Bariatric Surgery: A Systematic Review, Obesity Surgery, vol.23, pp.1922-1933, 2013. ,
Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans, The Journal of Clinical Endocrinology & Metabolism, vol.85, p.9, 2000. ,
Soluble CD163, a macrophage activation marker, is independently associated with fibrosis in patients with chronic viral hepatitis B and C, Hepatology, vol.60, pp.521-530, 2014. ,
Deletion of Shp2 in the Brain Leads to Defective Proliferation and Differentiation in Neural Stem Cells and Early Postnatal Lethality, Molecular and Cellular Biology, vol.27, pp.6706-6717, 2007. ,
Diverse Biochemical Properties of Shp2 Mutants: IMPLICATIONS FOR DISEASE PHENOTYPES, Journal of Biological Chemistry, vol.280, pp.30984-30993, 2005. ,
PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience, Journal of Medical Genetics, vol.41, pp.117-117, 2004. ,
Intermuscular and perimuscular fat expansion in obesity correlates with skeletal muscle T cell and macrophage infiltration and insulin resistance, International Journal of Obesity, vol.39, pp.1607-1618, 2015. ,
Targeted Disruption of Shp2 in Chondrocytes Leads to Metachondromatosis With Multiple Cartilaginous Protrusions: A NOVEL METACHONDROMATOSIS MOUSE MODEL, Journal of Bone and Mineral Research, vol.29, pp.761-769, 2014. ,
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice, Journal of Biological Chemistry, vol.275, pp.8456-8460, 2000. ,
Src kinases as therapeutic targets for cancer, Nature Reviews Clinical Oncology, vol.6, pp.587-595, 2009. ,
The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic b cell growth, The Journal of Clinical Investigation, vol.110, pp.1839-1847, 2002. ,
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion: Effects on -Cell Sensitivity in Type 2 and Nondiabetic Subjects, Diabetes, vol.52, pp.380-386, 2003. ,
Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice, Molecular and Cellular Biology, vol.20, pp.5479-5489, 2000. ,
Reduction In The Incidence Of Type 2 Diabetes With Lifestyle Intervention Or Metformin, New England Journal of Medicine, vol.346, pp.393-403, 2002. ,
(Shp2) Mutations in LEOPARD Syndrome Have Dominant Negative, Not Activating, Effects, Journal of Biological Chemistry, vol.281, pp.6785-6792, 2006. ,
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism, Nature, vol.437, pp.1109-1114, 2005. ,
GLUT4 glucose transporter deficiency increases hepatic lipid production and peripheral lipid utilization, Journal of Clinical Investigation, vol.114, pp.1666-1675, 2004. ,
Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence, European Journal of Medical Genetics, vol.52, pp.337-340, 2009. ,
Pleiotropic genes for metabolic syndrome and inflammation, Molecular Genetics and Metabolism, vol.112, pp.317-338, 2014. ,
Development of Diabesity in Mice with Neuronal Deletion of Shp2 Tyrosine Phosphatase, The American Journal of Pathology, vol.172, pp.1312-1324, 2008. ,
Cancer spectrum and frequency among children with Noonan, Costello and cardio-facio-cutaneous syndromes, 2015. ,
, British Journal of Cancer, vol.112, pp.1392-1397
Noonan Syndrome Mutation Q79R in Shp2 Increases Proliferation of Valve Primordia Mesenchymal Cells via Extracellular Signal-Regulated Kinase 1/2 Signaling, Circulation Research, vol.97, pp.813-820, 2005. ,
Role of ERK1/2 signaling in congenital valve malformations in Noonan syndrome, Proceedings of the National Academy of Sciences, vol.105, pp.18930-18935, 2008. ,
Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease, Proceedings of the National Academy of Sciences, vol.108, pp.16381-16385, 2011. ,
Insulin Hypersensitivity and Resistance to Streptozotocin-Induced Diabetes in Mice Lacking PTEN in Adipose Tissue, Molecular and Cellular Biology, vol.25, pp.2498-2510, 2005. ,
Apoptosis inhibitor of macrophage (AIM) is required for obesity-associated recruitment of inflammatory macrophages into adipose tissue, Proceedings of the National Academy of Sciences, vol.108, pp.12072-12077, 2011. ,
Regulation of metabolism by the innate immune system, Nature Reviews Endocrinology, vol.12, pp.15-28, 2016. ,
Increased Gut Permeability and Microbiota Change Associate with Mesenteric Fat Inflammation and Metabolic Dysfunction in Diet-Induced Obese Mice RR Zhang, PLoS ONE, vol.7, p.34233, 2012. ,
PTPN11-Associated Mutations in the Heart: Has LEOPARD Changed Its RASpots?, Trends in Cardiovascular Medicine, vol.21, pp.97-104, 2011. ,
The role of the protein tyrosine phosphatase SHP2 in cardiac development and disease, Seminars in Cell & Developmental Biology, vol.37, pp.73-81, 2015. ,
Common Acute Lymphoblastic Leukemia in a Girl With Genetically Confirmed LEOPARD Syndrome, Journal of Pediatric Hematology/Oncology, vol.30, pp.602-604, 2008. ,
Glucose Suppression of Glucagon Secretion: METABOLIC AND CALCIUM RESPONSES FROM ?-CELLS IN INTACT MOUSE PANCREATIC ISLETS, Journal of Biological Chemistry, vol.285, pp.14389-14398, 2010. ,
Activation of the SH2-containing Phosphotyrosine Phosphatase SH-PTP2 by Its Binding Site, Phosphotyrosine 1009, on the Human Platelet-derived Growth Factor Receptor B*, Journal of Biological Chemistry, vol.268, pp.21478-21481, 1993. ,
A suggested role for mitochondria in Noonan syndrome, Biochimica et Biophysica Acta, vol.1802, pp.275-283, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00562941
Mechanism and treatment for learning and memory deficits in mouse models of Noonan syndrome, Nature Neuroscience, vol.17, pp.1736-1743, 2014. ,
PTPN11 mutations in LEOPARD syndrome, Journal of Medical Genetics, vol.39, pp.571-574, 2002. ,
Understanding Growth Failure in Costello Syndrome: Increased Resting Energy Expenditure, The Journal of Pediatrics, vol.170, pp.322-324, 2016. ,
Regulation of glucose transport by insulin: traffic control of GLUT4, Nature Reviews Molecular Cell Biology, vol.13, pp.383-396, 2012. ,
PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer. Science, New Series, vol.275, pp.1943-1947, 1997. ,
Adipocyte NCoR Knockout Decreases PPAR? Phosphorylation and Enhances PPAR? Activity and Insulin Sensitivity, Cell, vol.147, pp.815-826, 2011. ,
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance, Cell, vol.167, pp.973-984, 2016. ,
LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes, Nature Medicine, vol.21, pp.239-247, 2015. ,
Glucagon-Like Peptide-1 Inhibits Pancreatic ATP-Sensitive Potassium Channels via a Protein Kinase A-and ADP-Dependent Mechanism, Molecular Endocrinology, vol.16, pp.2135-2144, 2002. ,
Regulation of IRS-1/SHP2 Interaction and AKT Phosphorylation in Animal Models of Insulin Resistance, Endocrine, vol.18, pp.1-12, 2002. ,
Prevalence and Clinical Significance of Cardiovascular Abnormalities in Patients With the LEOPARD Syndrome, The American Journal of Cardiology, vol.100, pp.736-741, 2007. ,
Genotype-phenotype analysis and natural history of left ventricular hypertrophy in LEOPARD syndrome, American Journal of Medical Genetics Part A, vol.146, pp.620-628, 2008. ,
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis, Blood, vol.103, pp.2325-2331, 2004. ,
Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia, Leukemia Research, vol.29, pp.459-462, 2005. ,
PI3K? inhibition reduces obesity in mice, Aging, vol.8, pp.2747-2753, 2016. ,
A1C Between 5.7 and 6.4% as a Marker for Identifying Pre-Diabetes, Insulin Sensitivity and Secretion, and Cardiovascular Risk Factors: The Insulin Resistance Atherosclerosis Study (IRAS), Diabetes Care, vol.33, pp.2104-2109, 2010. ,
Site-Specific Incorporation of a Phosphotyrosine Mimetic Reveals a Role for Tyrosine Phosphorylation of SHP-2 in Cell Signaling, Molecular Cell, vol.8, pp.759-769, 2001. ,
Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations, Journal of Lipid Research, vol.49, pp.2582-2589, 2008. ,
, Differential Hematopoietic Activity in White Adipose Tissue Depending on its Localization: SITE-SPECIFIC HEMATOPOIETIC ACTIVITY IN WAT, vol.230, pp.3076-3083, 2015.
Obesity induces a phenotypic switch in adipose tissue macrophage polarization, Journal of Clinical Investigation, vol.117, pp.175-184, 2007. ,
Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells, Cell Reports, vol.17, pp.2979-2993, 2016. ,
PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity, Cellular Signalling, vol.20, pp.684-694, 2008. ,
Glucose-induced ? cell production of IL-1? contributes to glucotoxicity in human pancreatic islets, The Journal of Clinical Investigation, vol.110, p.11, 2002. ,
Intrahepatic Diacylglycerol Content Is Associated With Hepatic Insulin Resistance in Obese Subjects, Gastroenterology, vol.142, pp.1444-1446, 2012. ,
Visualizing the origins of selfish de novo mutations in individual seminiferous tubules of human testes, Proceedings of the National Academy of Sciences, vol.113, pp.2454-2459, 2016. ,
The Stimulus-secretion Coupling of Amino Acid-induced Insulin Release, Diabetes, vol.29, p.7, 1980. ,
Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway, American Journal of Medical Genetics Part A, vol.158, pp.2700-2706, 2012. ,
Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation, Journal of Clinical Investigation, vol.121, pp.1026-1043, 2011. ,
The Tyrosine Phosphatase SHP-2 Is Required for Sustained Activation of Extracellular Signal-Regulated Kinase, p.223, 2000. ,
, Epithelial Morphogenesis Downstream from the Met Receptor Tyrosine Kinase, Molecular and Cellular Biology, vol.20, pp.8513-8525
Counteracting Effects Operating on Src Homology 2 Domain-containing Protein-tyrosine Phosphatase, vol.2, 2012. ,
, Function Drive Selection of the Recurrent Y62D and Y63C Substitutions in Noonan Syndrome, Journal of Biological Chemistry, vol.287, pp.27066-27077
Diverse driving forces underlie the invariant occurrence of the T42A, E139D, I282V and T468M SHP2 amino acid substitutions causing Noonan and LEOPARD syndromes, Human Molecular Genetics, vol.17, pp.2018-2029, 2008. ,
LEOPARD Syndrome: Clinical Features and Gene Mutations, Molecular Syndromology, 2012. ,
The developing story of Sprouty and cancer, Cancer and Metastasis Reviews, vol.33, pp.695-720, 2014. ,
Altered Glucose Homeostasis in Mice with Liver-specific Deletion of Src Homology Phosphatase 2, Journal of Biological Chemistry, vol.285, pp.39750-39758, 2010. ,
Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man, Diabetologia, pp.412-419, 1985. ,
Reduced expression of the murine p85? subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes, Journal of Clinical Investigation, vol.109, pp.141-149, 2002. ,
Role of innate and adaptive immunity in obesity-associated metabolic disease, Journal of Clinical Investigation, vol.127, pp.5-13, 2017. ,
Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters, Proceedings of the National Academy of Sciences, vol.90, pp.3865-3869, 1993. ,
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis, Cell, vol.145, pp.607-621, 2011. ,
Isolation of a distinct class of gain-of-function SHP-2 mutants with oncogenic RAS-like transforming activity from solid tumors, Oncogene, vol.27, pp.3508-3515, 2008. ,
Effect of Pioglitazone on Abdominal Fat Distribution and Insulin Sensitivity in Type 2 Diabetic Patients, The Journal of Clinical Endocrinology & Metabolism, vol.87, pp.2784-2791, 2002. ,
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations, Cancer Cell, vol.7, pp.179-191, 2005. ,
A Novel Role for Gab1 and SHP2 in Epidermal Growth Factor-induced Ras Activation, Journal of Biological Chemistry, vol.280, pp.5350-5360, 2005. ,
Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice, Diabetes, vol.64, pp.1120-1130, 2015. ,
Pathogenesis of Multiple Lentigines in LEOPARD Syndrome with PTPN11 Gene Mutation, Acta Dermato Venereologica, vol.95, pp.978-984, 2015. ,
Myeloid Dysregulation in a Human Induced Pluripotent Stem Cell Model of PTPN11 -Associated Juvenile Myelomonocytic Leukemia, Cell Reports, vol.13, pp.504-515, 2015. ,
Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines, Immunity, vol.41, pp.14-20, 2014. ,
The COOH-terminal Tyrosine Phosphorylation Sites on IRS-1 Bind SHP-2 and Negatively Regulate Insulin Signaling, Journal of Biological Chemistry, vol.273, pp.26908-26914, 1998. ,
Hepatic Src Homology Phosphatase 2 Regulates Energy Balance in Mice, Endocrinology, vol.153, pp.3158-3169, 2012. ,
Mediating ERK1/2 signaling rescues congenital heart defects in a mouse model of Noonan syndrome, Journal of Clinical Investigation, vol.117, pp.2123-2132, 2007. ,
Noonan syndrome is associated with enhanced pERK activity, the repression of which can prevent craniofacial malformations, Proceedings of the National Academy of Sciences, vol.106, pp.15436-15441, 2009. ,
Thiazolidinediones as antidiabetic agents: A critical review, Bioorganic Chemistry, vol.77, pp.548-567, 2018. ,
Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*, The Journal of Clinical Endocrinology & Metabolism, vol.63, pp.492-498, 1986. ,
, Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4?4 million participants, The Lancet, vol.387, pp.1513-1530, 2016.
Structure and function of SH2-domain containing tyrosine phosphatases, Cell Biology, vol.4, pp.419-432, 1993. ,
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling, Trends in Biochemical Sciences, vol.28, pp.284-293, 2003. ,
The Ability of Protein Tyrosine Phosphatase SHP-1 to Suppress NFkB Can Be Inhibited by Dominant Negative Mutant of SIRPa, DNA and Cell Biology, vol.23, pp.175-182, 2004. ,
Conditional Deletion of Shp2 Tyrosine Phosphatase in Thymocytes Suppresses Both Pre-TCR and TCR Signals, The Journal of Immunology, vol.177, pp.5990-5996, 2006. ,
Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia, Journal of Human Genetics, vol.50, pp.192-202, 2005. ,
Physicochemical mechanisms of protein regulation by phosphorylation, Frontiers in Genetics, vol.5, 2014. ,
Deletion of Apoptosis Inhibitor of Macrophage (AIM)/CD5L Attenuates the Inflammatory Response and Infarct Size in Acute Myocardial Infarction, Journal of the American Heart Association, vol.5, p.2863, 2016. ,
Role of SH-PTP2, a protein-tyrosine phosphatase with Src homology 2 domains, in insulin-stimulated Ras activation, Molecular and Cellular Biology, vol.14, pp.6674-6682, 1994. ,
Fatty Acid Signaling in the -Cell and Insulin Secretion, Diabetes, vol.55, pp.16-23, 2006. ,
Hypertelorism with Turner Phenotype: A new Syndrome with Associated Congenital Heart Disease, American Journal of Disease of Children, vol.116, pp.373-380, 1968. ,
The Role of Inflammation in ?-cell Dedifferentiation, Scientific Reports, p.7, 2017. ,
An islet in distress: ? cell failure in type 2 diabetes, Journal of Diabetes Investigation, 2010. ,
Transgenic Drosophila models of Noonan syndrome causing PTPN11 gain-of-function mutations, Human Molecular Genetics, vol.15, pp.543-553, 2006. ,
Phosphatase-defective LEOPARD syndrome mutations in PTPN11 gene have gain-of-function effects during Drosophila development, Human Molecular Genetics, vol.18, pp.193-201, 2009. ,
Identification of -cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA, Proceedings of the National Academy of Sciences, vol.99, pp.6737-6742, 2002. ,
Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies: Metabolic syndrome, Obesity Reviews, vol.16, pp.1-12, 2015. ,
Pharmacological Inhibition of PI3K Reduces Adiposity and Metabolic Syndrome in Obese Mice and Rhesus Monkeys, Cell Metabolism, vol.21, pp.558-570, 2015. ,
Hyperosmotic stress activates the insulin receptor in CHO cells, Biochimica et Biophysica Acta (BBA) -Molecular Cell Research, vol.1540, pp.97-106, 2001. ,
Targeting the ERK signaling pathway as a potential treatment for insulin resistance and type 2 diabetes, American Journal of Physiology-Endocrinology and Metabolism, vol.310, pp.643-651, 2016. ,
The Rasopathy family: Consequences of germline activation of the RAS/MAPK pathway, Endocrine Reviews, 2018. ,
The Phosphatase SHP2 Regulates the Spacing Effect for Long-Term Memory Induction, Cell, vol.139, pp.186-198, 2009. ,
Mutations as a Cause of Constitutive Insulin Sensitivity and Obesity, New England Journal of Medicine, vol.367, pp.1002-1011, 2012. ,
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy, Nature Genetics, vol.39, pp.1007-1012, 2007. ,
Protein Tyrosine Phosphatase 1B and Insulin Resistance: Role of Endoplasmic Reticulum Stress/Reactive Oxygen Species/Nuclear Factor Kappa B Axis M Ushio-Fukai, Ed. PLoS ONE, vol.8, p.77228, 2013. ,
Troglitazone Regulation of Glucose Metabolism in Human Skeletal Muscle Cultures from Obese Type II Diabetic Subjects, Journal of Clinical Endocrinology and Metabolism, vol.83, pp.1636-1643, 1998. ,
Glucocorticoids and Thiazolidinediones Interfere with Adipocyte-mediated Macrophage Chemotaxis and Recruitment, Journal of Biological Chemistry, vol.284, pp.31223-31235, 2009. ,
Role of Peripheral Inflammatory Markers in Postoperative Cognitive Dysfunction (POCD): A Meta-Analysis K Hashimoto, PLoS ONE, vol.8, p.79624, 2013. ,
Protein-tyrosine-phosphatase 2C is phosphorylated and inhibited by 44-kDa mitogen-activated protein kinase, Proceedings of the National Academy of Sciences, vol.91, pp.5002-5006, 1994. ,
corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso, Cell, vol.70, pp.225-236, 1992. ,
Early Lymphocyte Expansion Is Severely Impaired in Interleukin 7 Receptor-deficient Mice, Journal of Experimental Medecine, vol.180, pp.1955-1960, 1994. ,
Enhancement in liver SREBP-1c/PPAR-? ratio and steatosis in obese patients: Correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion, Biochimica et Biophysica Acta, vol.1792, pp.1080-1086, 2009. ,
Emerging treatment options for type 2 diabetes: Emerging therapies for type 2 diabetes, British Journal of Clinical Pharmacology, vol.70, pp.631-644, 2010. ,
Fructose-1, 6-Bisphosphatase Inhibitors for Reducing Excessive Endogenous Glucose Production in Type 2 Diabetes, Diabetes -Perspectives in Drug Therapy, M Schwanstecher, pp.279-301, 2011. ,
Regulation of the Insulin Gene by Glucose and Fatty Acids, The Journal of Nutrition, vol.136, pp.873-876, 2006. ,
Tub Has a Key Role in Insulin and Leptin Signaling and Action In Vivo in Hypothalamic Nuclei, Diabetes, vol.62, pp.137-148, 2013. ,
Cardiovascular disease in Noonan syndrome, Archives of Disease in Childhood, vol.99, pp.629-634, 2014. ,
Deletion of Shp2 Tyrosine Phosphatase in Muscle Leads to Dilated Cardiomyopathy, Insulin Resistance, and Premature Death, Molecular and Cellular Biology, vol.29, pp.378-388, 2009. ,
From heterogeneity to plasticity in adipose tissues: Site-specific differences, Experimental Cell Research, vol.312, pp.727-736, 2006. ,
Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells, British Journal of Haematology, vol.129, pp.118-129, 2005. ,
Activation of NF-B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes, Proceedings of the National Academy of Sciences, vol.98, pp.6668-6673, 2001. ,
Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11), BMC Structural Biology, vol.14, p.10, 2014. ,
A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development, Molecular and Cellular Biology, vol.17, pp.5499-5507, 1997. ,
, , 1998.
, Mutant Cells. Molecular and Cellular Biology, vol.18, pp.6075-6082
Autoimmune disease and multiple autoantibodies in 42 patients with RASopathies, American Journal of Medical Genetics Part A, vol.158, pp.1077-1082, 2012. ,
Roles of Gab1 and SHP2 in Paxillin Tyrosine Dephosphorylation and Src Activation in Response to Epidermal Growth Factor, Journal of Biological Chemistry, vol.279, pp.8497-8505, 2004. ,
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes, Nature Reviews Drug Discovery, vol.15, pp.786-804, 2016. ,
Targeting hepatic glucose metabolism in the treatment of type 2 diabetes, Nature Reviews Drug Discovery, vol.15, pp.786-804, 2016. ,
The current role of thiazolidinediones in diabetes management, Archives of Toxicology, vol.90, pp.1861-1881, 2016. ,
Noonan syndrome. The Lancet, vol.381, pp.333-342, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00562941
Interaction of SH2-Containing Protein Tyrosine Phosphatase 2 with the Insulin Receptor and the Insulin-Like Growth Factor-I Receptor: Studies of the Domains Involved Using the Yeast Two-Hybrid System, Endocrinology, vol.137, pp.4944-4952, 1996. ,
A Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimuli, Diabetes, vol.53, pp.1007-1019, 2004. ,
Proglucagon is processed to glucagon by prohormone convertase PC2 in aTC1-6 cells, vol.91, pp.3242-3246, 1994. ,
SOCS-1 and SOCS-3 Block Insulin Signaling by Ubiquitin-mediated Degradation of IRS1 and IRS2, Journal of Biological Chemistry, vol.277, pp.42394-42398, 2002. ,
The src Homology 2 Domain-Containing Tyrosine Phosphatase 2 Regulates Primary T-Dependent Immune Responses and Th Cell Differentiation, The Journal of Immunology, vol.175, pp.6498-6508, 2005. ,
Effects of polyamines on mitochondrial Ca2+ transport, Biochimica et Biophysica Acta (BBA) -Biomembranes, pp.113-124, 1661. ,
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease, Journal of Biological Chemistry, vol.279, pp.32345-32353, 2004. ,
Inhibition of protein kinase C? prevents hepatic insulin resistance in nonalcoholic fatty liver disease, Journal of Clinical Investigation, vol.117, pp.739-745, 2007. ,
Validity and reproducibility of HOMA-IR, 1/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes, Journal of Human Hypertension, vol.21, pp.709-716, 2007. ,
Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex, Science, vol.307, pp.1098-1101, 2005. ,
Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome, Journal of Medical Genetics, vol.41, pp.68-68, 2004. ,
Germline BRAF mutations in Noonan, LEOPARD, and cardiofaciocutaneous syndromes: Molecular diversity and associated phenotypic spectrum, Human Mutation, vol.30, pp.695-702, 2009. ,
Leopard syndrome, Orphanet Journal of Rare Diseases, vol.3, p.13, 2008. ,
Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2, Proceedings of the National Academy of Sciences, vol.96, pp.3790-3795, 1999. ,
Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2, The EMBO Journal, vol.16, pp.2352-2364, 1997. ,
New Approaches to Prevent LEOPARD Syndromeassociated Cardiac Hypertrophy by Specifically Targeting Shp2-dependent Signaling, Journal of Biological Chemistry, vol.288, pp.18335-18344, 2013. ,
The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling, 2012. ,
, American Journal of Physiology-Heart and Circulatory Physiology, vol.302, pp.231-243
Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury, Biochemical Pharmacology, vol.77, pp.1827-1834, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00493505
Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells, Nature Communications, vol.7, p.233, 2016. ,
Malignant melanoma in a woman with LEOPARD syndrome: identification of a germline PTPN11 mutation and a somatic BRAF mutation, British Journal of Dermatology, vol.157, pp.1267-1304, 2007. ,
Regulation of Src homology 2-containing protein tyrosine phosphatase by advanced glycation end products: the role on atherosclerosis in diabetes, Metabolism, vol.56, pp.1591-1598, 2007. ,
Interleukin-6 Induces Cellular Insulin Resistance in Hepatocytes, Diabetes, vol.51, pp.3391-3399, 2002. ,
Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature, Proceedings of the National Academy of Sciences, vol.109, pp.4257-4262, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-00756494
Fetal cardiac screening and variation in prenatal detection rates of congenital heart disease: why bother with screening at all? Future Cardiology, vol.8, pp.189-202, 2012. ,
The natural history of Noonan syndrome: a long-term follow-up study, Archives of Disease in Childhood, vol.92, pp.128-132, 2006. ,
Overexpression of Suppressor of Cytokine Signaling 3 in Adipose Tissue Causes Local but Not Systemic Insulin Resistance, Diabetes, vol.55, pp.699-707, 2006. ,
Macrophage plasticity and polarization: in vivo veritas, Journal of Clinical Investigation, vol.122, pp.787-795, 2012. ,
Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature, American Journal of Medical Genetics Part A, vol.173, pp.1061-1065, 2017. ,
Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity, Nature Medicine, vol.11, pp.199-205, 2005. ,
Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPAR? and PPAR?, Journal of Biological Chemistry, vol.283, pp.29109-29118, 2008. ,
Whole-Genome Sequencing of a Single Proband Together with Linkage Analysis Identifies a Mendelian Disease Gene GS Barsh, PLoS Genetics, vol.6, p.1000991, 2010. ,
Does the Metabolic Syndrome Improve Identification of Individuals at Risk of Type 2 Diabetes and/or Cardiovascular Disease? Diabetes Care, vol.27, pp.2676-2681, 2004. ,
Phosphatase-Dependent and -Independent Functions of Shp2 in Neural Crest Cells Underlie LEOPARD Syndrome Pathogenesis, Developmental Cell, vol.18, pp.750-762, 2010. ,
Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity, vol.101, pp.2082-2087, 2004. ,
Inflammation is a modulator of the insulin-like growth factor (IGF)/IGF-binding protein system inducing reduced bioactivity of IGFs in cystic fibrosis, European Journal of Endocrinology, vol.154, pp.47-52, 2006. ,
Juvenile myelomonocytic leukemia. Hématologie, pp.144-153, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01938513
Dysfunction of Inflammation-Resolving Pathways Is Associated with Exaggerated Postoperative Cognitive Decline in a Rat Model of the Metabolic Syndrome, Molecular Medecine, vol.18, pp.1481-1490, 2012. ,
Activation of glycolysis and apoptosis in glycogen storage disease type Ia, Molecular Genetics and Metabolism, vol.97, pp.267-271, 2009. ,
Antagonism between binding site affinity and conformational dynamics tunes alternative cis-interactions within Shp2, Nature Communications, p.4, 2013. ,
Role of diacylglycerol activation of PKC? in lipid-induced muscle insulin resistance in humans, Proceedings of the National Academy of Sciences, vol.111, pp.9597-9602, 2014. ,
LEOPARD syndromeassociated SHP2 mutation confers leanness and protection from diet-induced obesity, Proceedings of the National Academy of Sciences, vol.111, pp.4494-4503, 2014. ,
Noonan syndrome-causing SHP2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth, Human Molecular Genetics, vol.27, pp.2276-2289, 2018. ,
SHP2 sails from physiology to pathology, European Journal of Medical Genetics, vol.58, pp.509-525, 2015. ,
The SH2-containing protein-tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early xenopus development, 1995. ,
, Cell, vol.80, pp.473-483
Myeloid-Specific Disruption of Tyrosine Phosphatase Shp2 Promotes Alternative Activation of Macrophages and Predisposes Mice to Pulmonary Fibrosis, The Journal of Immunology, vol.193, pp.2801-2811, 2014. ,
Noonan syndrome and clinically related disorders, Best Practice & Research Clinical Endocrinology & Metabolism, vol.25, pp.161-179, 2011. ,
Somatic PTPN11 mutations in childhood acute myeloid leukaemia, British Journal of Haematology, vol.129, pp.333-339, 2005. ,
Diversity and Functional Consequences of Germline and Somatic PTPN11 Mutations in Human Disease, The American Journal of Human Genetics, vol.78, pp.279-290, 2006. ,
Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome, Nature Genetics, vol.29, pp.465-468, 2001. ,
Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia, Nature Genetics, vol.34, pp.148-150, 2003. ,
Noonan Syndrome: Clinical Aspects and Molecular Pathogenesis, Molecular Syndromology, vol.1, pp.2-26, 2010. ,
Mutation-specific signaling profiles and kinase inhibitor sensitivities of juvenile myelomonocytic leukemia revealed by induced pluripotent stem cells, Leukemia, 2018. ,
Interleukin-1 beta modulates the growth and phenotype of neonatal rat cardiac myocytes, Journal of Clinical Investigation, vol.96, pp.1093-1099, 1995. ,
Adipose-derived circulating miRNAs regulate gene expression in other tissues, Nature, vol.542, pp.450-455, 2017. ,
Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient-and obesity-induced insulin resistance, Proceedings of the National Academy of Sciences, vol.104, pp.14056-14061, 2007. ,
YAP and TAZ, Hippo Signaling Targets, Act as a Rheostat for Nuclear SHP2 Function, Developmental Cell, vol.26, pp.658-665, 2013. ,
Acute Myelomonocytic Leukemia in a Boy With LEOPARD Syndrome (PTPN11 Gene Mutation Positive), Journal of Pediatric Hematology/Oncology, vol.28, pp.123-125, 2006. ,
Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms, Molecular and Cellular Biology, vol.24, pp.5434-5446, 2004. ,
Expression of Dominant Negative Mutant SHPTP2 Attenuates Phosphatidylinositol 3?-Kinase Activity via Modulation of Phosphorylation of Insulin Receptor Substrate-1, Journal of Biological Chemistry, vol.271, pp.12595-12602, 1996. ,
Absence of S6K1 protects against age-and diet-induced obesity while enhancing insulin sensitivity, Nature, vol.431, pp.200-205, 2004. ,
Protection from obesity-induced insulin resistance in mice lacking TNF-? function, Nature, vol.389, p.5, 1997. ,
Direct effect of insulin and insulin-like growth factor-I on the secretory activity of rat pancreatic beta cells, Diabetologia, vol.33, pp.649-653, 1990. ,
Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport, Cell Reports, vol.21, pp.1021-1035, 2017. ,
, , 2001.
, Intramyocellular Lipid Is Associated With Resistance to In Vivo Insulin Actions on Glucose Uptake, Antilipolysis, and Early Insulin Signaling Pathways in Human Skeletal Muscle, vol.50, pp.2337-2343
Multiple in Vivo Phosphorylated Tyrosine Phosphatase SHP-2 Engages Binding to Grb2 via Tyrosine 584, Cell Growth & Differentiation, vol.7, pp.1589-1597, 1996. ,
Molecular basis of juvenile myelomonocytic leukemia, Haematologica, vol.95, pp.179-182, 2010. ,
Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus, Journal of Clinical Investigation, vol.126, pp.2077-2092, 2016. ,
Predicting grain yield and protein content in wheat by fusing multi-sensor and multi-temporal remote-sensing images, Field Crops Research, vol.164, pp.178-188, 2014. ,
Chronic TNF-? Neutralization Does Not Improve Insulin Resistance or Endothelial Function in "Healthy, Men with Metabolic Syndrome. Molecular Medecine, vol.17, pp.189-193, 2011. ,
Muscle-Specific Pten Deletion Protects against Insulin Resistance and Diabetes, Molecular and Cellular Biology, vol.25, pp.1135-1145, 2005. ,
The importance of weight management in type 2 diabetes mellitus, International Journal of Clinical Practice, vol.68, pp.682-691, 2014. ,
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition, Nature Medicine, vol.24, pp.968-977, 2018. ,
Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity, Diabetologia, vol.50, pp.395-403, 2007. ,
, , 1998.
, Lentiginosis/LEOPARD Syndrome Presenting as Sudden Cardiac Arrest, Chest, vol.113, pp.1415-1417
A Conserved Mechanism for Control of Human and Mouse Embryonic Stem Cell Pluripotency and Differentiation by Shp2 Tyrosine Phosphatase M Capogrossi, PLoS ONE, vol.4, p.4914, 2009. ,
Skeletal muscle inflammation and insulin resistance in obesity, Journal of Clinical Investigation, vol.127, pp.43-54, 2017. ,
SHP-2 Is a Dual-specificity Phosphatase Involved in Stat1 Dephosphorylation at Both Tyrosine and Serine Residues in Nuclei, Journal of Biological Chemistry, vol.277, pp.47572-47580, 2002. ,
Non-lineage/stage-restricted effects of a gainof-function mutation in tyrosine phosphatase Ptpn11 (Shp2) on malignant transformation of hematopoietic cells, The Journal of Experimental Medicine, vol.208, pp.1977-1988, 2011. ,
Activating Mutations in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhance Reactive Oxygen Species Production That Contributes to Myeloproliferative Disorder KD Bunting, PLoS ONE, vol.8, p.63152, 2013. ,
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, The Journal of Clinical Investigation, vol.112, pp.1821-1830, 2003. ,
Role of the Protein Tyrosine Phosphatase Shp2 in Homeostasis of the Intestinal Epithelium R Sugiura, PLoS ONE, vol.9, p.92904, 2014. ,
An Shp2/SFK/Ras/Erk Signaling Pathway Controls Trophoblast Stem Cell Survival, Developmental Cell, vol.10, pp.317-327, 2006. ,
Shp2 confers cisplatin resistance in small cell lung cancer via an AKT-mediated increase in CA916798, Oncotarget, vol.8, 2017. ,
Activating PTPN11 mutants promote hematopoietic progenitor cell-cycle progression and survival, Experimental Hematology, vol.36, pp.1285-1296, 2008. ,
Severity, Duration, and Mechanisms of Insulin Resistance during Acute Infections*, The Journal of Clinical Endocrinology & Metabolism, vol.69, pp.317-323, 1989. ,
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1, Nature, vol.413, pp.131-138, 2001. ,
Modulation of the Nuclear Factor B Pathway by, p.2, 2001. ,
, Tyrosine Phosphatase in Mediating the Induction of Interleukin (IL)-6 by IL-1 or Tumor Necrosis Factor, vol.9
Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway, Molecular and Cellular Biology, vol.19, pp.2416-2424, 1999. ,
Structural and Mechanistic Insights into LEOPARD Syndrome-Associated SHP2 Mutations, Journal of Biological Chemistry, vol.288, pp.10472-10482, 2013. ,
SHP2 phosphatase as a novel therapeutic target for melanoma treatment, Oncotarget, p.7, 2016. ,
Receptor-Specific Regulation of Phosphatidylinositol 3'-Kinase Activation by the Protein Tyrosine Phosphatase Shp2, Molecular and Cellular Biology, vol.22, pp.4062-4072, 2002. ,
Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment, Molecular Cell, vol.13, pp.341-355, 2004. ,
Negative Regulation of Stat3 by Activating PTPN11 Mutants Contributes to the Pathogenesis of Noonan Syndrome and Juvenile Myelomonocytic Leukemia, Journal of Biological Chemistry, vol.284, pp.22353-22363, 2009. ,
The p110 isoform of PI3K is essential for proper growth factor signaling and oncogenic transformation, Proceedings of the National Academy of Sciences, vol.103, pp.16296-16300, 2006. ,
The Islet Cell-enriched MafA Activator Is a Key Regulator of Insulin Gene Transcription, Journal of Biological Chemistry, vol.280, pp.11887-11894, 2005. ,
Shp2 Deficiency Impairs the Inflammatory Response Against Haemophilus influenzae by Regulating Macrophage Polarization, Journal of Infectious Diseases, vol.214, pp.625-633, 2016. ,
Induction of a Tumor-associated Activating Mutation in Protein Tyrosine Phosphatase Ptpn11 (Shp2) Enhances Mitochondrial Metabolism, Leading to Oxidative Stress and Senescence, Journal of Biological Chemistry, vol.288, pp.25727-25738, 2013. ,
Gain-of-function mutations in the gene encoding the tyrosine phosphatase SHP2 induce hydrocephalus in a catalytically dependent manner, Science Signaling, p.1591, 2018. ,